Title: CTSI newsletter
ALL VOLUMES CITATION PDF VIEWER THUMBNAILS PAGE IMAGE ZOOMABLE
Full Citation
STANDARD VIEW MARC VIEW
Permanent Link: http://ufdc.ufl.edu/UF00090016/00008
 Material Information
Title: CTSI newsletter
Series Title: CTSI newsletter
Physical Description: Serial
Language: English
Creator: Clinical and Translational Science Institute, University of Florida
Publisher: Clinical and Translational Science Institute
Place of Publication: Gainesville, Fla.
Publication Date: March 2009
 Record Information
Bibliographic ID: UF00090016
Volume ID: VID00008
Source Institution: University of Florida
Holding Location: University of Florida
Rights Management: All rights reserved by the source institution and holding location.

Downloads

This item has the following downloads:

march2009 ( PDF )


Full Text















From the Director


A New RFA!


Who's Eligible?

Some Helpful
Resources

CTSI S&P Cmte
Program and Core
Directors/Mentors

The Last Page....


Volume 2, Issue 2 March 2009

Volume 2, Issue 2 March 2009


INSIDE T ^HIISU I


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700


Have good news and very good news to share regarding two newsworthy
items; I will leave it to you to determine which deserves the higher rank.
First, the NIH review of our round of CTSA applications is completed,
and it appears that the University of Florida's proposal may have ranked num-
ber two in the country, making us highly competitive for obtaining a five-year
CTSA award beginning later this year. The summary statement of the applica-
tion should be released in April and the award notice should come roughly
a month thereafter, for an expected start of funding on July 1, 2009. Further
details will be forthcoming in subsequent Newsletters as we learn them.

The second item of good news is that this edition of the Newsletter is a
reissuance of the CTSI's RFA that was inaugurated last fall. What follows is
more or less a recapitulation of the original RFA announcement with a few
important modifications of the formatting of proposals and the manner in
which they will be peer-reviewed. Those of you who applied before and were
unsuccessful and those of you who have yet to apply are encouraged to do so.
As before, there are four categories that span the CTS investigator spectrum
from graduate students to established faculty members. So, let your creative
juices flow in innovative, and even risky, ways. That's the purpose of the CTSI
Pilot and Collaborative Projects Program.

Good luck!






Peter W. Stacpoole, PhD, MD
Director, General Clinical Research Center
Director Clinical and Translational Science Institute
Associate Dean Clinical Research and Training














Volume 2, Issue 2 March 2009

A NW RA!


The CTSI's Pilot and Collaborative
Research Projects Program
How early in the investigation and research
process can you decide whether the researcher
is on a fruitful path? How does one gauge
whether to risk investing in a researcher's idea long
before it evolves into a substantive proposal for extra-
mural funding? These questions frame a recurring
dilemma for division chiefs, department chairs, center
and institute directors and college deans: how to con-
tinuously nurture creativity among trainees and faculty
while maintaining their fiduciary responsibilities to a
broader constituency. These questions are particularly
relevant to academia today, when federal support for
investigator-initiated biomedical research is at low
ebb.

Administrators can't afford to let their spending priori-
ties be set by the constantly shifting winds of extramu-
ral funding. Indeed, periods of relative drought in
federal awards are precisely those times that demand
significant and sustained internal support of faculty
and trainees to maximize their competitiveness for
extramural funding. Accordingly, UF is committed to
encouraging and enabling the development of promis-
ing but nascent projects across a broad spectrum of
scientific endeavors by CTSI investigators. We intend
to grow this program substantially in future years
from both institutional and extramural sources through
twice-yearly Request for Applications (RFAs) an-
nounced through this Newsletter. This fall, we begin
by providing seed funds allocated among the follow-
ing categories:

Category 1: To increase opportunities to transform
exciting and innovative CTS ideas by graduate stu-


dents and junior faculty into proof of concept, we will
provide up to $50,000 in new pilot grant awards and
encourage competitive proposals from trainees early in
their research careers.

Category 2: To encourage development of novel
methods and technologies relevant to CTS, the CTSI
faculty and mentored trainees will be eligible to
compete for awards totaling up to $50,000 to support
fundamentally new methodological (e.g., biostatistics,
ethics) or technological (e.g., medical device, analyti-
cal instrumentation) developments.

Category 3: To stimulate interdisciplinary research in
CTS through the CTSI's Major Initiatives Program,
by providing up to $150,000 and a new mechanism to
forge collaborations among new and established inves-
tigators across scientific disciplines. The expectation
is that the success of this program will increase UF's
ability to garner large extramural grants and contacts
based on interdisciplinary CTS.

Translational Funding Opportunities
To receive consideration for funding, research
proposals must focus on the translation of preclinical
studies to humans (T1) or the translation of clinical
research/clinical trials to community engagement and
clinical practice (T2). Individual pilot proposals from
graduate students and Clinical Scholars must reflect a
new research approach or direction for the applicant,
not originally identified or considered in his or her
initial research plan. In other words, the funds sought
through this program must help transform the investi-
gator's original scope of research, including its antici-
pated outcomes. This year's allocation of funds is


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.265.273.8700















Volume 2, Issue 2 March 2009

ANWRA!


summarized in Table 1.

The Program's diverse functions will be self-sustain-
ing, supported primarily by fees, and portions of re-
search funding it receives when investigators write Re-
search Design and Analysis Program (RDAP) services
into their grants. Experts provide grant-writing help at
no cost to investigators who request in their proposals
funding to cover the Program's services.

Pilot Project Review
Each review will be conducted by primary and sec-
ondary reviewers who will be members of the Pro-
gram's Executive Advisory Committee (Table 2 on
page 4).


If an award is made through the Pilot and Collabora-
tive Projects Program, the awardee then works with
the Office of Budget Development and Negotiations to
finalize the allocation of the awarded funds and set in
place a tracking system to maintain communication
with the investigator regarding the timing of the initial
of the grant and its progress. Each awardee is required
to submit an annual progress report to the Institute,
which will consider requests for up to a one year no-
cost extension of the original award.


Table 1. Funding Categories for CTSI Pilot and Collaborative Projects.
Areas of Support Available Funding ceiling/ Estimated max. # new
Funds1 project projects this yr
Student $15,000 $7,500 2
Junior Faculty $35,000 $20,000 2
Novel Methods & Technologies $50,000 $25,000 2
Major Initiatives2 $150,000 $100,000 2
1 One year awards, with no-cost carryover in year 2 possible.
2 Minimum of 2 PIs from different colleges.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700










[TS1 New s! eter II

Volume 2, Issue 2 March 2009



Table 2. Pilot and Collaborative Projects Program Executive Committee.
Member Role in CTSI Program
Peter Stacpoole (co-director) Director, CTSI
N. Lawrence Edwards (co-director) Chair, Scientific Advisory Committee
Christopher Batich Associate Director, Operations
Michael Conlon Associate Director, Biomedical Informatics
R. Peter lafrate Director, Regulatory Knowledge and Research Support Program
Marian Limacher Director, Training and Professional Development Program
Jesse Gregory Director, Translational Technologies and Resources Program
Keith Muller Co-Director, Research Design and Analysis Program
Jon Shuster Co-Director, Research Design and Analysis Program


DATES TO R


Deadline for Electronic Submission to
CTSI (candy.caputo@ctsi.ufl.edu)
April 24, 2009

Proposal Review
May 8, 2009

Award Announcements
May 15, 2009

Earliest Date of Funding
June 1, 2009


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700














Volume 2, Issue 2 March 2009


A Familiar Format
Proposals to the Pilot and Collaborative Projects
Program will share a common format that
is similar to those currently used by the GCRC
and the UF Opportunity Fund. An abstract should
summarize the proposed work. Proposals can include
up to 5 pages, according to the NIH R01 format, to
describe:

Hypotheses and Specific Aims;
Preliminary Studies;
Design and Methodologies (including statistical
considerations and need for specific CTSI resources
(e.g., technology cores; patient research
venues, etc.).

An NIH-formatted list of References must be append-
ed, followed by a list of the individuals to be involved
in the project and details of their participation. In the
case of applicants who are being mentored (graduate
students and K 30 Clinical Scholars), a one-half
to one page summary of the Mentoring Plan and the
mentoring environments) is required. A detailed
Budget and Justification of expenses can include all
normally allowable costs of research (including meet-
ings with off-campus collaborators) with the exception
of faculty salaries, student stipends and indirect costs.
A specific start date not later than September 1, 2009,
should be given. If none is specified, the Program will
assume a start date one month after award notification,
or approximately two months after the receipt of
applications.

Each applicant must also describe, in up to one page,
plans to obtain continuing external support (in the case
of Major Initiatives), to use Program funds in further-


ing career objectives (students and Clinical Scholars),
or to develop the commercial potential of new meth-
ods or technologies developed with Program support.
This latter description should include a statement of
potential market size and how funding could increase
the marketability of the technology.

Consistent Evaluation
Applications will be scored on the following
criteria:

1. originality and innovation;
2. significance in the field of study;
3. relationship of the proposal to the current research
direction of the applicant;
4. likelihood of meeting stated aims within 1-2
years;
5. research environment (including qualifications of
mentors, if applicable); and
6. plans and likelihood for future funding (not required
of graduate students).

Proposals will be assigned priority scores according
to NIH guidelines; the appropriateness of the budget
request will not be a factor in determining the priority
score. A brief Summary Statement will be provided
each applicant that identifies strengths and weaknesses
of the application and the allocation of funds, if
awarded. A composite priority score is generated that
will serve as a means of prioritizing applications.
Generally, only those proposals that receive a priority
score in the "Outstanding" (<150) or "Excellent" (151-
200) range will be considered for funding. Thus, it is
possible that less than the minimum number of awards
per category may be made in any year. Revised appli-
cations may be submitted twice.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700














Volume 2, Issue 2 March 2009


Tracking Evaluation and
Acknowledgment
Awardees will be expected to provide a brief semi-
annual report during the active funding period outlin-
ing the progress of their projects. At the end of the
funding period and annually thereafter for at least the
next three years, awardees will be asked to provide
summaries of their proposals in terms of the success
in meeting the original objectives. We will also need
information on published abstracts, papers and pre-
sentations at scientific meetings relevant to the funded
project, and information reporting grant submissions
based on data generated from that project. Awardees
will be asked to complete a brief questionnaire at the
end of the funding period regarding the effective-
ness of the Pilot and Collaborative Projects Program,
including the application process, proposal review
and funding mechanisms. All publications based on
funds provided by the CTSI's RFA should contain the
following statement "Supported in part by funds from
the University of Florida's Clinical and Translational
Science Institute." Lastly, investigators who receive
extramural funding based on a CTSI seed grant are
asked to request that the Division of Sponsored Re-
search make the appropriate indirect cost allocation to
the CTSI.


Students
Graduate students who have been engaged for at least
1 year in a terminal certificate or degree program will
be eligible to compete for a one-time individual pilot
grant award of up to $7,500 each. Students must be
conducting research under the auspices of one or more
members of the CTSI's Mentoring Core of faculty
who represent the 12 colleges currently participating


in the CTSI. Members of the Mentoring Core were
carefully chosen by their deans and their college's
CTSI Steering and Planning Committee representa-
tives to undertake this mentoring role. The mentors,
and their email addresses, can be found in Table 3 on
page 11. More faculty undoubtedly will join this core
over time.

Individuals seeking a Clinical Research Coordinator
certificate or an MS, MPH or PhD with an emphasis
in CTS (including those enrolled in a T32 program)
are eligible to apply. Moreover, the Program's Mentor-
ing Core of faculty also has one graduate student
representative from each participating CTSI college
as ex-officio members of the Core. For the purposes of
pilot project internal award competition, one student
representative will be assigned as a tertiary reviewer
for each application. This individual will evaluate the
mentoring environment of the applicant and the merit
of the applicant's use of the requested funds to further
his or her research objectives.

The CTSI is committed to providing enhanced oppor-
tunities to underrepresented ethnic and racial minori-
ties (women are already extremely well-represented
at all levels of graduate study at UF). Therefore, the
Program intends to earmark in future years at least
one award per year for talented minority graduate
student applicants and at least one award per year
for talented minority Clinical Scholar applicants.
Furthermore, to encourage and promote community-
based studies in pediatrics, the Program will earmark
at least one award per year for a graduate student and
one awardper year for a Clinical Scholar to conduct
research in this area.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.265.273.8700















Volume 2, Issue 2 March 2009


An Example of a Student Proposal
For her thesis project, a graduate student is con-
ducting T1 (bench to bedside) research by develop-
ing a knockdown of a gene, using small, interfering
RNA, to create an animal model of an embryonic
lethal human genetic disease. During the course
of her experiments, she learns of new insights into
the behavioral phenotype of affected humans from
recently published literature. This causes her to re-
assess a previously neglected aspect of her original
plan to investigate genotypephenotype relationships
in her animal model. From consultation with the
CTSI's Biobehavioral Core (contact: Dr. Sara Jo
Nixon at: sjnixon@ufl.edu), she learns about vali-
dated experimental behavior testing methods that
could be applied to extend her characterization of
the animals and better determine their applicability
as a model of human disease. She applies to the Pi-
lot and Collaborative Projects Program for funding
to support the costs of obtaining relevant expert
faculty guidance and use of equipment in the
Biobehavioral Core to facilitate this new research
objective.


Junior Faculty
Tenure-track faculty at the Assistant or early Associate
Professor level who have been enrolled in the CTSI
Clinical Research Scholars Program (currently restrict-
ed to those enrolled in UF's K30 APPCI Program)
for at least 6 months or who have an active NIH 'K'
award are eligible to compete for a one-time award
of up to $20,000. Clinical Scholars must be conduct-
ing mentored research toward an MS, MPH or PhD
in CTS. Trainees early in their careers gain first-hand
experience in the process of grant writing and grant
review involving their own research.


An Example of a Junior Faculty
Member Proposal
A Clinical Research Scholar in Gainesville is
investigating the kinetics and biotransformation of
a pro-drug used in the treatment of hypertension.
As part of his original proposal for the CR Schol-
ars program, he has identified a novel glutathione
transferase (GST) in human liver that is respon-
sible for the conversion of the pro-drug to its active
metabolite. During this process, he discovers three
isoforms of the gene that, by using the resources
of the CTSI DNA/Tissue Bank Core (contact: Dr.
James Crawford at: Crawford ( paithology.ufl.edu),
appear to be unequally distributed among different
ethnic and racial groups. Further in vitro studies by
the investigator determine significant differences
in the Km and Vmax for the pro-drug among the 3
GST isoforms. Although his original intent was to
conduct limited pharmacokinetic studies in a few
subjects in the GCRC at Shands Hospital on the
Gainesville campus, he now recognizes the potential
of extending these studies across ethnic and racial
groups. After consulting with the CTSI's Communi-
ty Engagement and Research Program (contact: Dr.
Elizabeth Shenkman at: eas@ichp.ufl.edu) and the
Pharmacogenomics Core (contact; Dr. Julie Johnson
at: Johnson@cop.ufl.edu) he submits a proposal to
the Pilot and Collaborative Projects Program to fund
an extension of his patient-oriented research to the
CTSI's Clinical Research Unit on the Jacksonville
campus (contact: Dr. Alan Berger at: alan.berger@
jax.ufl.edu). This strategy to strengthen his T2 (clini-
cal research to community engagement) investiga-
tions will allow him to engage a wide and a diverse
community in participatory research involving
population genotyping and recruitment of subjects
on both UF campuses to examine ethnic and racial
differences in drug metabolism.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700














Volume 2, Issue 2 March 2009




Novel Technologies and Methodologies
CTSI faculty and mentored graduate students are eligible to compete for awards of up to $25,000 each. Unlike
one-time individual pilot awards to graduate students or Clinical Scholars, an applicant is eligible to receive
successive awards to support fundamentally new research projects in methodological (e.g., biostatistical, ethics)
or technological (e.g., medical device, analytical instrumentation) development, providing awards are spaced at
least 3 years apart.


An Example of a Novel Technologies and Methodologies Proposal
A CTSI biostatistician is assisting a Clinical Scholar who is an Assistant Professor in the Department
of Anesthesiology. The investigator is PI on a clinical trial designed to shorten hospital stays of patients
undergoing total hip replacement surgery by employing a combination of continuous femoral nerve blocks
and aggressive physical therapy. This is important T2 research because, as hospitals and outpatient surgi-
cal centers become increasingly able to provide 24/7 monitoring for patients, the time to meeting discharge
criteria is now a continuous outcome variable. Further, because some patients never meet these discharge
criteria (some may need to be discharged before meeting them, some may need further unexpected care,
or a small number may die in hospital), the right-censored nature of the data precludes the use of ordinary
parametric statistics. Consequently, the biostatistician applies under the auspices of the Novel Methods
and Technologies program to fund the development of new software to analyze trial data of this type and
to address two previously unsolved problems whose solutions would be important in conducting hospital
discharge-related trials: 1) can the proposed methods be extended to account for covariates; and 2) can
the methods accommodate random effects? Both problems would make excellent thesis topics for future
graduate students who seek PhDs in Biostatistics with an emphasis in CTS (the CTSI's T32 program; Sec-
tion 12). Thus, such a proposal links the initial investment of support of the biostatistician with new oppor-
tunities for training in T2 research.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.265.273.8700











II New slette


Volume 2, Issue 2 March 2009




Interdisciplinary Research in CTS through the CTSI's Major Initiatives Program
Tenured and tenure-track faculty who form an interdisciplinary collaboration are eligible to compete as
multiple PIs for 2-year awards of up to $100,000 in total costs. Applicants are eligible to receive successive
awards as PIs to support fundamental new projects in CTS, providing awards are spaced at least 4 years apart.





An Example of a Major Initiatives Program Proposal
A group of faculty members from various disciplines in the Departments of Food Science and Human Nutrition,
Biomedical Engineering, Pediatrics and Chemistry decide to collaborate on a study of the neurological basis,
metabolic profile and treatment of refractory epilepsy in children. The engineer has patented a new instrument
for recording electrical brain activity that provides superior computer-assisted discriminatory power in differ-
entiating subtle epileptiform spikes from other wave patterns. The pediatric neurologist runs a regional clinic
for epilepsy and has conducted prior research on patients using the sleep-study room in the GCRC (contact: Dr.
Peter Stacpoole at: stacpool@gcrc.ufl.edu). The food scientist has also used the GCRC to investigate the effects
of ketogenic diets of various fatty acid compositions on patient tolerability and seizure frequency by collaborat-
ing with the neurologist. The analytical chemist has developed novel
mass spectrometric techniques to create metabolite 'platforms,' by which quantitative information can be ob-
tained from plasma and skin fibroblasts or other tissues regarding mitochondrial pathways of fuel metabolism.

Although distinguished in their own fields of T research, previous interactions among these
investigators have been limited. The engineer uses the registry of faculty researchers maintained by the
CTSI's Research Portal (still a work in progress!) to initiate contact with the other investigators. The
team eventually develops a proposal for a Major Initiative submission to the Pilot and Collaborative Projects
Program to generate preliminary studies and to show a track record of collaboration in preparation
for an eventual Program Project or large R01 application. In their proposal they request support to conduct
proof-of-concept studies in the GCRC on the application of the new electroencephalographic device and on the
effects of ketogenic diets on seizure activity in relation to both dietary fatty acid composition and metabolic
changes in patients' plasma and cultured cells. Funds are requested for consultative support from the CTSI's
Research Design and Analysis Program, the Clinical and Research Ethics Program and the Metabolomics Core
(contact: Dr. David Powell at: (powell@chem.ufl.edu) and funds to hire a part-time Clinical Research Coordi-
nator (contact: Ms. Teresa D'angelo, RN, at: danget@shands.ufl.edu), purchase laboratory supplies and cover
routine ancillary patient care costs. They also request travel funds to present their initial
findings at a national pediatric neurology meeting.


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.265.273.8700














Volume 2, Issue 2 March 2009

SOM HEPU RESORCE


Useful CTSI Programs for Grant
Proposals
In the first CTSI Newsletter, we summarized the
various programs that are coming online to facili-
tate CTS research. For the purposes of this inau-
gural CTSI Request For Applications (RFA), some
relevant Institute resources include the following:

The Office of Regulatory Affairs and Licensing pro-
vides for assistance in facilitating research and training
in FDA-compliant matters of investigational drugs,
biologics, nanoparticles and devices. This office pro-
vides full-service consultations on all regulatory mat-
ters and will assist the investigator in writing appropri-
ate IND and IDE applications, when required. Contact
Dr. Wajeeh Bajwa at: bajwaw@gcrc.ufl.edu.

The applicant may also engage the resources of the
Office of Budget Development and Negotiations. This
office will assist in constructing a budget for the pro-
posal within the guidelines established by the Pilot and
Collaborative Projects Program. Contact Ms. Candy
Caputo at: caputcl@medicine.ufl.edu.

If the proposed pilot project includes research involv-
ing vertebrate animals or clinical research (as defined
by NIH guidelines), the investigator may solicit advice
from the Clinical and Research Ethics Program. This
program includes experts in all aspects of the ethical
conduct of animal and human research; the ethics of
drug production, distribution and use; the practices
and procedures of IRBs and IACUCs; and related in-
formation essential to crafting a proposal and consent
form consistent with local and federal ethical and
regulatory guidelines. Contact Bob Kolb, RN, CCRC
at: kolbb@gcrc.ufl.edu.


In addition, the applicant may also require further
consultation from the Research Design and Analysis
Program (RDAP) and the Biomedical Informatics Pro-
gram (BMIP) to ensure hypotheses are based on valid
study design and biostatistical considerations and that
appropriate informatics resources are available for the
acquisition, management and analysis of data. Contact
Dr. Keith Muller at: keith.muller@biostat.ufl.edu for
the RDAP and Dr. Mike Conlon at: mconlon@ufl.edu
for the BMIP


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700











II New slette


Volume 2, Issue 2 March 2009





CTSI S&P Committee Program and Core Directors/Mentors

Name E-mail College
Allegra, Carmen carmen.allegra@medicine.ufl.edu COM
Allen, William wmallen@ufl.edu COM
Andresen, Elena andresen@phhp.ufl.edu CPHHP
Antony, Veena veena.antony@medicine.ufl.edu COM
Atkinson, Mark akinson@ufl.edu COM
Batich, Chris cbati@ufl.edu COE
Bauer, Russ rbauer@phhp.ufl.edu CPHHP
Berger, Alan R. alan.berger@jac.ufl.edu COM-Jax
Beyth, Rebecca rbeyth@aging.ufl.edu COM
Block, Edward edward.block@medicine.ufl.edu COM
Bodor, Nicholas nbodor@ufl.edu COP
Bova, Frank bova@ufl.edu COM
Bowers, Dawn dbowers@phhp.ufl.edu CPHHP
Braith, Randy rbraith@ufl.edu CHHP
Brantly, Mark mark.brantly@medicine.ufl.edu COM
Brushwood, David brushwood@cop.ufl.edu COP
Burne, Robert rburne@dental.ufl.edu COD
Bussing, Regina rbussing@ufl.edu COM
Byrne, Barry bbyme@ufl.edu COM
Cance, William cance@surgery.ufl.edu COM
Cauraugh, James H. jcaura@hhp.ufl.edu CHHP
Choi, Youjin ychoi@jou.ufl.edu COJ
Clare-Salzler, Michael salzler@ufl.edu COM
Conlon, Michael mconlon@ufl.edu BMI
Crawford, James crawford@ufl.edu COM
Dennis, Donn ddennis@anest.ufl.edu COM
Ding, Mingzhou mzding@ufl.edu COE
Edison, Art aedison@ufl.edu COM
Elder, Jennifer elderjh@ufl.edu CON


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700












Volume 2, Issue 2 March 2009

Volume 2, Issue 2 March 2009

[TSI S&P1 CMTE PROGRAM E CORE DlUIREC]I ITO (INi


CTSI S&P Committee Program and Core Directors/Mentors

Name E-mail College
Elder, Jennifer elderjh@ufl.edu CON
Ferguson, Mary Ann mferguson@jou.ufl.edu COJ
Ferl, Rob robferl@ufl.edu CALS
Fillingim, Roger rfilling@ufl.edu COD
Foster, Thomas foster@mbi.ufl.edu COM
Garrett, Timothy J. garrett@gcrc.ufl.edu COM
Ghivizzani, Steve sghiv@ufl.edu COM
Goodenow, Maureen goodenow@ufl.edu COM
Grant, Maria maria.grant@medicine.ufl.edu COM
Gregory, Jesse F., III jfgy@ufl.edu CALS
Haskell-Luevano, Carrie chaskell@ufl.edu COP
Hochhaus, Guenther hochhaus@cop.ufl.edu COP
Hon, Linda lhon@jou.ufl.edu COJC
Horgas, Ann L. ahorgas@ufl.edu CON
Howland, Dena howland@mbi.ufl.edu COM
Hsu, Stephen hsusi@medicine.ufl.edu COM
Iafrate, R. Peter Iafrate@shands.ufl.edu SHANDS
Johnson, Julie A johnson@cop.ufl.edu COP
Kautz, Steven kautz159@phhp.ufl.edu CPHHP
Keller-Wood, Maureen kellerwd@cop.ufl.edu COP
Lauzardo, Michael lauzam@medicine.ufl.edu COM
Leeuwenburgh, Christiaan cleeuwen@aging.ufl.edu COM
Limacher, Marian marian.limacher@medicine.ufl.edu COM
Magnusson, Ingvar imagnusson@dental.ufl.edu COD
Mann, William wmann@phhp.ufl.edu CPHHP
Marsiske, Michael mmarsisk@phhp.ufl.edu CPHHP
McCormack, Wayne mccormac@pathology.ufl.edu COM
Meador, Kimford kimford.meador@neurology.ufl.edu COM
Moldawer, Lyle moldawer@surgery.ufl.edu COM


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700











II New slette


Volume 2, Issue 2 March 2009





CTSI S&P Committee Program and Core Directors/Mentors

Name E-mail College
Morel, Laurence morel@pathology.uf. edu COM
Muller, Keith keith.muller@biostat.ufl.edu COM
Murphy, Tania tmurphy@ufl.edu COM
Nelson, David david.nelson@medicine.ufl.edu COM
Nixon, Sara sjnixon@ufl.edu COM
Okun, Michael okun@neurology.ufl.edu COM
Oliverio, James C. oliverio@ufl.edu CFA
Pahor, Marco mpahor@ufl.edu COM
Pepine, Carl carl.pepine@medicine.ufl.edu COM
Percival, Susan S. percival@ufl.edu CALS
Petersen, Bryon petersen@pathology.ufl.edu COM
Powell, David powell@chem.ufl.edu CLAS
Progulske-Fox, Ann apfox@ufl.edu COD
Ranka, Sanjay ranka@cise.ufl.edu COE
Rathore, Mobeen Mobeen.rathore@jax.ufl.edu COM
Reeves, Westley whreeves@ufl.edu COM
Riley, Joseph JRILEY@dental.ufl.edu COD
Roberts, Stephen smr@ufl.edu CVM
Robinson, Michael merobin@nersp.nerdc.ufl.edu CPHHP
Rothi, Leslie gonzalj@neurology.ufl.edu COM
Sapienza, Christine sapienza@csd.ufl.edu CLAS
Scarpace, Phil scarpace@ufl.edu COM
Schatz, Desmond schatz@ufl.edu COM
Scott, Edward escott@ufl.edu COM
Shenkman, Elizabeth eas@ichp.ufl.edu COM
Sheps, David shepsds@medicine.ufl.edu COM
Shorr, Ron rshorr@aging.ufl.edu COM
Shuster, Jon jshuster@biostat.ufl.edu COM


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700











II New slette


Volume 2, Issue 2 March 2009





CTSI S&P Committee Program and Core Directors/Mentors

Name E-mail College
Siemann, Dietmar siemadw@ufl.edu COM
Southwick, Fredrick frederick. southwick@medicine.ufl.edu COM
Srivastava, Arun arun@peds.ufl.edu COM
Stacpoole, Peter W. pws@ctsi.ufl.edu COM
Staud, Roland staudr@ufl.edu COM
Stechmiller, Joyce stechjk@ufl.edu CON
Steindler, Dennis steindler@mbi.ufl.edu COM
Swaminathan, Sankar sswamina@ufl.edu COM
Thompson, Floyd Thompson@mbi.ufl.edu COM
Treise, Deborah M. dtreise@jou.ufl.edu COJ
Vandenborne, Krista kvandenb@phhp.ufl.edu CPHHP
Vieweg, Johannes j.vieweg@urology.ufl.edu COM
Wagenaar, Alexander wagenaar@ufl.edu COM
Walsh-Childers, Kim kwchilders@jou.ufl.edu COJ
Werch, Chudley cwerch@hhp.ufl.edu CHHP
White, Keith kdwhite@ufl.edu CLAS
Wingard, John john.wingard@medicine.ufl.edu COM
Wood, Charles woodc@ufl.edu COM
Yost, Richard A. ryost@chem.ufl.edu CLAS
Youngblade, Lise Imy@ichp.ufl.edu COM


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700















Volume 2, Issue 2 March 2009

THE L~~AS PA E..


Employment
Did you know that there are multiple venues through which both internal and external jobs are posted?

For Job Seekers
https://jobs.ufl.edu University of Florida jobs postings.
http://www.union.ufl.edu/jobs/ Reitz Union student job listings.
http://www.sfa.ufl.edu/programs/workstudy Federal Work-Study Program.
http://www.sfa.ufl.edu/programs/ops.html Other Personnel Services jobs.
http://www.sfa.ufl.edu/programs/oce.html Off-Campus jobs.
http://www.sfa.ufl.edu/programs/vaworkstudy.html Veteran's Affairs Work-Study.







Subscribe to the CTSI Newsletter
Ensure that you receive future editions of this Newsletter by subscribing to the CTSI-ANNOUNCE-L
Listserv. It's quick and easy to do and will allow you to also receive other CTSI announcements as
they are distributed. To subscribe, simply send an email to listserv@lists.ufl.edu with the message:

SUBSCRIBE CTSI-ANNOUNCE-L your-first-name your-last-name


Clinical and Translational Science Institute University of Florida Gainesville, FL 352.273.8700




University of Florida Home Page
© 2004 - 2010 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Last updated October 10, 2010 - - mvs